HCT Regenerative is the first and only company in Taiwan to focus on processing human tissue to provide regenerative biomaterials for clinical use. Through our know-how and strategic relationships, our aim is to become the leading tissue bank in Asia. Our continued mission is to develop advanced human cellular and tissue based products (HCT/Ps) to improve patients' quality of life. Our current products include amnion membrane allografts, amnion matrix allografts, and spinal allografts that are utilized in orthopedic surgeries, sports medicine, trauma, wound management, plastic surgery, dental and more. HCT Regenerative is also open to contract processing for companies looking to enter the Asian market or for those wishing to find a reliable partner in the region.
View Top Employees from HCT Regenerative 醫晟生醫Website | http://www.hctregenerative.com |
Revenue | $5 million |
Employees | 9 (5 on RocketReach) |
Founded | 2016 |
Phone | +886 2 2808 5202 |
Industry | Biotechnology Research, Business Services General, Regenerative medicine, Business Services, Biotechnology |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular HCT Regenerative 醫晟生醫 employee's phone or email?
The HCT Regenerative 醫晟生醫 annual revenue was $5 million in 2024.
Dana Shires is the Business Operations, Board of Director of HCT Regenerative 醫晟生醫.
5 people are employed at HCT Regenerative 醫晟生醫.
The NAICS codes for HCT Regenerative 醫晟生醫 are [541, 5417, 541713, 54171, 54].
The SIC codes for HCT Regenerative 醫晟生醫 are [87, 873].